Topical Ocular Delivery of NSAIDs
Open Access
- 25 April 2008
- journal article
- review article
- Published by Springer Nature in The AAPS Journal
- Vol. 10 (2) , 229-241
Abstract
In ocular tissue, arachidonic acid is metabolized by cyclooxygenase to prostaglandins which are the most important lipid derived mediators of inflammation.Keywords
This publication has 85 references indexed in Scilit:
- Topical Pranoprofen 0.1% Is As Effective Anti-Inflammatory and Analgesic Agent as Diclofenac Sodium 0.1% After Strabismus SurgeryJournal of Ocular Pharmacology and Therapeutics, 2007
- Aqueous, oil, and ointment formulations of ketorolac: efficacy against prostaglandin E2-induced ocular inflammation and safety: A technical noteAAPS PharmSciTech, 2006
- Gellan-Based Scleral Implants of Indomethacin: In Vitro and In Vivo EvaluationDrug Delivery, 2004
- Pharmacological Profile of Oxaprozin Eye DropsJournal of Ocular Pharmacology and Therapeutics, 2002
- Development of Model Aqueous Ophthalmic Solution of IndomethacinDrug Development and Industrial Pharmacy, 2000
- Specificity of Flurbiprofen and Enantiomers for Inhibition of Prostaglandin Synthesis in Bovine Iris/Ciliary BodyProstaglandins & Other Lipid Mediators, 1998
- Pharmacological Evaluation of Anti-Inflammatory Pyrrole-Acetic Acid Derivative Eye DropsJournal of Ocular Pharmacology and Therapeutics, 1997
- Biopharmaceutical evaluation of ibufenac, ibuprofen, and their hydroxyethoxy analogs in the rabbit eyeJournal of Pharmacokinetics and Biopharmaceutics, 1992
- Bendazac LysineDrugs, 1990
- Ocular and systemic bioavailability of ophthalmic flurbiprofenJournal of Pharmacokinetics and Biopharmaceutics, 1984